More clarity over a life time of Statin therapy
Researchers from University of London (UCL) have announced that Statin therapy for cholesterol reduction seems to cost more and have less benefit for patients 40 years or older.The UCL research team called on doctors to discuss the risks more clearly with patients since long periods of time on this type of medication causes weakness to cardiac muscle tissue.
One of the report's authors, Prof John Yudkin, told the BBC: "What it means is if you're someone with type-2, it's your right to know what the benefits of the treatment are in terms of gain in life expectancy or reduction in heart attacks or going blind. "And then you are entitled to decide, but not many doctors have got those figures to hand."He said GPs were too "target focused" and were often looking only at the blood sugar level.